Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

13.16 +1.36 (+11.53%)
Streaming Delayed Price Updated: 2:47 PM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
News headline image
Psychedelic And Cannabis Drug Stocks Continue Advance ↗
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
Via Talk Markets
News headline image
Mind Medicine, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC: RVVTF) shares closed up 2.51% at $0.22 LOSERS: Mind Medicine (NASDAQ: MNMD) shares closed down 8.09% at $1.25 Cybin (AMEX:CYBN) shares closed down 6.25% at $1.05 ATAI... 
Via Benzinga
News headline image
Allied, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 7.39% at $1.89 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 9, 2022 ↗
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 14.29% at $5.76 
Via Benzinga
News headline image
Cathie Wood Is Buying this Peter Thiel-Backed Psychedelics Stock For Ark Funds ↗
There’s a new psychedelics company being added to an ETF from Cathie Wood. What Happened: The Ark Genomic Revolution ETF (BATS: ARKG) took an initial position in shares of... 
Via Benzinga
News headline image
Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Awakn Life Sciences (OTC:AWKNF) shares closed up 3.51% at $1.62 
Via Benzinga
News headline image
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 9.82% at $1.23 
Via Benzinga
News headline image
Is The Psychedelics Sector In Decline? This $30M VC Fund Says HOLD ↗
This article was originally published on Microdose and appears here with permission. Recently, there has been an exciting discussion in LinkedIn posts and Microdose PsyCap events regarding the presumed... 
Via Benzinga
News headline image
Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.29% at $0.20 
Via Benzinga
News headline image
Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.29% at $0.19 
Via Benzinga
News headline image
Mind Medicine, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 5.04% at $0.17 
Via Benzinga
News headline image
New Psychedelics ETF Launches On NYSE Arca ↗
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)... 
Via Benzinga
News headline image
Mindset Pharma, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 15.70% at $0.69 
Via Benzinga
News headline image
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.89% at $5.33 
Via Benzinga
News headline image
Has A Sugar Daddy Emerged In The Psychedelic Drug Industry? ↗
One very large drug multinational has already been active in writing checks to finance drug development in the psychedelic drug industry. 
Via Talk Markets
News headline image
The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January ↗
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From January 28, 2022 ↗
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 17.86% at $0.57 
Via Benzinga
News headline image
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 6.29% at $0.49 
Via Benzinga
News headline image
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC: 
Via Benzinga
News headline image
Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 24, 2022 ↗
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
News headline image
Psyched: Eleusis To Go Public Via Merger, New Psychedelics Bills In Utah, Virginia, Kansas And Missouri ↗
Psychedelics Legalization Gains Momentum Around The Country: Bills Introduced In Utah, Virginia, Kansas And Missouri A wave of psychede... 
Via Benzinga
News headline image
Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD ↗
This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From January 21, 2022 ↗
GAINERS: GH Research (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 20, 2022 ↗
GAINERS: Small Pharma (OTC: 
Via Benzinga
News headline image
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC: 
Via Benzinga
News headline image
Two-Thirds Of Physicians Say Psilocybin Therapy Can Help Treatment-Resistant Depression, New Survey Shows ↗
Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: 
Via Benzinga
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – January 19, 2022 – After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of... 
Via FinancialNewsMedia
News headline image
Psychedelic Stock Gainers And Losers From January 18, 2022 ↗
GAINERS: Cybin (AMEX: 
Via Benzinga
News headline image
Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington ↗
Canada Opens New Legal Pathways For Access To Treatment With Psilocybin And MDMA In a groundbreaking decision, the Canadian gov... 
Via Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.